SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-12-043832
Filing Date
2012-06-15
Accepted
2012-06-15 12:44:12
Documents
6
Effectiveness Date
2012-06-15

Document Format Files

Seq Description Document Type Size
1 S-8 a12-14744_1s8.htm S-8 96190
2 EX-5.1 a12-14744_1ex5d1.htm EX-5.1 7364
3 EX-23.1 a12-14744_1ex23d1.htm EX-23.1 3733
4 EX-24.1 a12-14744_1ex24d1.htm EX-24.1 8686
5 GRAPHIC g147441kki001.gif GRAPHIC 5885
6 GRAPHIC g147441kki002.gif GRAPHIC 1819
  Complete submission text file 0001104659-12-043832.txt   128059
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-182142 | Film No.: 12909488
SIC: 2835 In Vitro & In Vivo Diagnostic Substances